Table 1.
Characteristics of the specimens that were discordant among the Mindray CL-900i anti-SARS-CoV-2 IgG, BioMérieux VidasIII anti-SARS-CoV-2 IgG, and Roche Elecsys Anti SARS-CoV-2 antibody testing.
Specimen number% | Record of PCR positive test prior to study£ | Date of blood and naso-pharyngeal swab specimens’ collection at time of study | PCR test at time of study | Mindray CL-900i anti-SARS-CoV-2 IgG* | BioMérieux VidasIII anti-SARS-CoV-2 IgG** | Roche Elecsys anti SARS-CoV-2*** | Symptomatic at time of study# | Severity at or right after time of study$ | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Test result | Test result | Ct value | Optical density | Test result | Optical density | Test result | Optical density | Test result | ||||
20 | N/A | 10-Aug-20 | Negative | 3.76 | Negative | 5.86 | Positive | 0.48 | Negative | No | N/A | |
21 | N/A | 10-Aug-20 | Negative | 111.72 | Positive | 0.45 | Negative | 67.27 | Positive | No | N/A | |
22 | N/A | 6-Aug-20 | Positive | 21.62 | 3.74 | Negative | 0.10 | Negative | 8.40 | Positive | Symptomatic | Severe |
29 | N/A | 27-Jul-20 | Negative | 5.81 | Negative | 1.08 | Positive | 5.62 | Positive | No | N/A | |
37 | N/A | 10-Aug-20 | Negative | 7.77 | Negative | 0.47 | Negative | 3.66 | Positive | No | N/A | |
40 | N/A | 29-Jul-20 | Negative | 20.24 | Positive | 0.01 | Negative | 0.16 | Negative | No | N/A | |
50 | N/A | 11-Aug-20 | Negative | 31.25 | Positive | 0.04 | Negative | 0.09 | Negative | No | N/A | |
61 | N/A | 29-Jul-20 | Negative | 135.05 | Positive | 0.45 | Negative | 38.01 | Positive | No | N/A | |
71 | N/A | 28-Jul-20 | Negative | 4.17 | Negative | 0.88 | Negative | 3.01 | Positive | No | N/A | |
82 | N/A | 10-Aug-20 | Negative | 71.76 | Positive | 0.02 | Negative | 0.08 | Negative | No | N/A | |
126 | N/A | 10-Aug-20 | Positive | 26.95 | 10.50 | Positive | 0.15 | Negative | 0.18 | Negative | No | N/A |
128 | N/A | 10-Aug-20 | Positive | 33.81 | 220.63 | Positive | 0.62 | Negative | 7.72 | Positive | No | N/A |
129 | N/A | 10-Aug-20 | Negative | 16.60 | Positive | 0.07 | Negative | 0.08 | Negative | No | N/A | |
131 | N/A | 13-Aug-20 | Positive | 28.32 | 36.22 | Positive | 0.46 | Negative | 9.23 | Positive | No | N/A |
137 | N/A | 10-Aug-20 | Negative | 4.72 | Negative | 0.46 | Negative | 10.98 | Positive | No | N/A | |
147 | N/A | 10-Aug-20 | Negative | 39.57 | Positive | 0.94 | Negative | 10.92 | Positive | No | N/A | |
174 | N/A | 29-Jul-20 | Positive | 24.09 | 12.05 | Positive | 1.29 | Positive | 0.12 | Negative | No | N/A |
182 | N/A | 29-Jul-20 | Negative | 11.22 | Positive | 0.35 | Negative | 0.07 | Negative | Not reported | N/A | |
191 | N/A | 10-Aug-20 | Negative | 7.87 | Negative | 1.75 | Positive | 8.41 | Positive | No | N/A | |
213 | N/A | 29-Jul-20 | Negative | 140.62 | Positive | 0.00 | Negative | 0.11 | Negative | No | N/A | |
223 | N/A | 10-Aug-20 | Negative | 7.29 | Negative | 4.73 | Positive | 7.35 | Positive | No | N/A | |
228 | N/A | 10-Aug-20 | Negative | 0.17 | Negative | 5.56 | Positive | 40.35 | Positive | No | N/A | |
232 | N/A | 29-Jul-20 | Positive | 23.89 | 16.48 | Positive | 0.19 | Negative | 0.09 | Negative | No | N/A |
246 | N/A | 10-Aug-20 | Negative | 5.60 | Negative | 1.37 | Positive | 6.98 | Positive | No | N/A | |
255 | N/A | 27-Jul-20 | Negative | 8.06 | Negative | 1.09 | Positive | 10.18 | Positive | No | N/A | |
280 | N/A | 29-Jul-20 | Positive | 32.34 | 20.61 | Positive | 2.30 | Positive | 0.51 | Negative | No | N/A |
296 | N/A | 27-Jul-20 | Negative | 15.7 | Positive | 0.04 | Negative | 0.15 | Negative | No | N/A | |
319 | N/A | 29-Jul-20 | Negative | 4.07 | Negative | 2.48 | Positive | 1.16 | Positive | No | N/A | |
328 | N/A | 29-Jul-20 | Negative | 6.41 | Negative | 0.68 | Negative | 2.59 | Positive | No | N/A | |
337 | N/A | 29-Jul-20 | Negative | 80.22 | Positive | 0.86 | Negative | 5.62 | Positive | No | N/A | |
355 | N/A | 29-Jul-20 | Positive | 29.18 | 2.36 | Negative | 2.11 | Positive | 0.10 | Negative | No | N/A |
357 | N/A | 29-Jul-20 | Negative | 10.49 | Positive | 3.34 | Positive | 0.73 | Negative | No | N/A | |
360 | N/A | 10-Aug-20 | Negative | 13.57 | Positive | 0.06 | Negative | 0.09 | Negative | No | N/A | |
376 | N/A | 10-Aug-20 | Negative | 45.70 | Positive | 0.07 | Negative | 0.09 | Negative | No | N/A | |
387 | N/A | 11-Aug-20 | Positive | 24.24 | 310.78 | Positive | 0.46 | Negative | 4.56 | Positive | No | N/A |
Ct cycle threshold, N/A not applicable, PCR polymerase chain reaction.
*Mindray CL-900i anti-SARS-CoV-2 IgG assay positive: optical-density cutoff index ≥ 10.0 vs. negative: cutoff index < 10.06.
**BioMérieux VidasIII assay positive: optical-density cutoff index ≥ 1.0 vs. negative: cutoff index < 1.07.
***Roche Elecsys Anti SARS-CoV-2 assay positive: optical-density cutoff index ≥ 1.0 vs. negative: cutoff index < 1.05.
%Specimen number consistent with Supplementary Table S1 in Supplementary Information.
£Date of first positive swab and Ct value are not available as there was no record for a prior positive swab for these specimens.
#Symptoms as reported in the medical record for this infection.
$Severity per WHO classification19. If N/A, no severity classification was conducted due to absence of serious symtoms to require hospitalization and severity assessment.